Correlation Between Corporate Office and Akebia Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Corporate Office and Akebia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corporate Office and Akebia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corporate Office Properties and Akebia Therapeutics, you can compare the effects of market volatilities on Corporate Office and Akebia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corporate Office with a short position of Akebia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corporate Office and Akebia Therapeutics.

Diversification Opportunities for Corporate Office and Akebia Therapeutics

0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between Corporate and Akebia is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Corporate Office Properties and Akebia Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akebia Therapeutics and Corporate Office is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corporate Office Properties are associated (or correlated) with Akebia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akebia Therapeutics has no effect on the direction of Corporate Office i.e., Corporate Office and Akebia Therapeutics go up and down completely randomly.

Pair Corralation between Corporate Office and Akebia Therapeutics

Assuming the 90 days horizon Corporate Office Properties is expected to generate 0.39 times more return on investment than Akebia Therapeutics. However, Corporate Office Properties is 2.56 times less risky than Akebia Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Akebia Therapeutics is currently generating about -0.03 per unit of risk. If you would invest  2,940  in Corporate Office Properties on September 14, 2024 and sell it today you would earn a total of  160.00  from holding Corporate Office Properties or generate 5.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Corporate Office Properties  vs.  Akebia Therapeutics

 Performance 
       Timeline  
Corporate Office Pro 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Corporate Office Properties are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Corporate Office reported solid returns over the last few months and may actually be approaching a breakup point.
Akebia Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Akebia Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Akebia Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Corporate Office and Akebia Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Corporate Office and Akebia Therapeutics

The main advantage of trading using opposite Corporate Office and Akebia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corporate Office position performs unexpectedly, Akebia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akebia Therapeutics will offset losses from the drop in Akebia Therapeutics' long position.
The idea behind Corporate Office Properties and Akebia Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm